Skip Navigation LinksHome > August 2014 - Volume 9 - Issue 8 > A Brief Report on Outcomes of Stereotactic Ablative Radiothe...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0000000000000218
Brief Reports

A Brief Report on Outcomes of Stereotactic Ablative Radiotherapy for a Second Primary Lung Cancer: Evidence in Support of Routine CT Surveillance

Griffioen, Gwendolyn H.M.J. MD; Lagerwaard, Frank J. MD, PhD; Haasbeek, Cornelis J.A. MD, PhD; Slotman, Ben J. MD, PhD; Senan, Suresh MRCP, FRCR, PhD

Collapse Box


New guidelines recommend the use of CT surveillance after a curative treatment for lung cancer as survivors have a 3–6% risk per person year of developing a second primary lung cancer. Our analysis of 107 patients with second primary lung cancer treated by stereotactic ablative radiotherapy showed a comparable 3 years overall survival (60%) and local control rate (89%) as for an initial lung cancer. Toxicity was uncommon, despite the fact that 73% of patients had undergone a prior (bi)lobectomy. Our findings indicate that CT surveillance is also appropriate in patients who may be unfit, or unwilling, to undergo surgery.

Copyright © 2014 by the European Lung Cancer Conference and the International Association for the Study of Lung Cancer.


Article Tools


Other Ways to Connect



Visit on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.